These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24456230)

  • 1. Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults.
    Pedro-Botet ML; Burgos J; Luján M; Gimenez M; Rello J; Planes A; Fontanals D; Casas I; Mateu L; Zuluaga P; Ardanuy C; Sabrià M
    Scand J Infect Dis; 2014 Mar; 46(3):185-92. PubMed ID: 24456230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory viruses, such as 2009 H1N1 influenza virus, could trigger temporal trends in serotypes causing pneumococcal disease.
    Launes C; García-García JJ; Triviño M; Peris N; Pallarés R; Muñoz-Almagro C
    Clin Microbiol Infect; 2014 Dec; 20(12):O1088-90. PubMed ID: 24977322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
    Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
    J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
    Harboe ZB; Benfield TL; Valentiner-Branth P; Hjuler T; Lambertsen L; Kaltoft M; Krogfelt K; Slotved HC; Christensen JJ; Konradsen HB
    Clin Infect Dis; 2010 Feb; 50(3):329-37. PubMed ID: 20047478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
    Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
    Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.
    Guevara M; Barricarte A; Gil-Setas A; García-Irure JJ; Beristain X; Torroba L; Petit A; Polo Vigas ME; Aguinaga A; Castilla J
    Clin Microbiol Infect; 2009 Nov; 15(11):1013-9. PubMed ID: 19673968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
    Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
    Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data.
    Chiavenna C; Presanis AM; Charlett A; de Lusignan S; Ladhani S; Pebody RG; De Angelis D
    PLoS Med; 2019 Jun; 16(6):e1002829. PubMed ID: 31246954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
    Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
    Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J; Benes C; Kriz P
    Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of invasive pneumococcal disease among elderly people in Southern Catalonia, Spain, 2002-2009: an increase in serotypes not contained in the heptavalent conjugate vaccine.
    Ochoa-Gondar O; Vila-Corcoles A
    J Infect; 2011 Dec; 63(6):434-40. PubMed ID: 21875616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.
    Yin Z; Rice BD; Waight P; Miller E; George R; Brown AE; Smith RD; Slack M; Delpech VC
    AIDS; 2012 Jan; 26(1):87-94. PubMed ID: 22008657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.
    Ardanuy C; Tubau F; Pallares R; Calatayud L; Domínguez MA; Rolo D; Grau I; Martín R; Liñares J
    Clin Infect Dis; 2009 Jan; 48(1):57-64. PubMed ID: 19035779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.